Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
0.7953
+0.0400 (5.30%)
At close: Nov 6, 2026, 4:00 PM EST
0.7950
-0.0003 (-0.04%)
After-hours: Nov 6, 2026, 7:30 PM EST
Cardiff Oncology Employees
As of December 31, 2025, Cardiff Oncology had 31 total employees, including 30 full-time and 1 part-time employees. The number of employees decreased by 2 or 6.06% compared to the previous year. That makes Cardiff Oncology the 36,959th largest employer in the world and 5,118th in the United States.
Employees
31
Change (1Y)
-2
Growth (1Y)
-6.06%
Revenue / Employee
$16,387
Profits / Employee
-$1,292,774
Market Cap
61.87M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 31 | -2 | -6.06% | 30 | 1 |
| Dec 31, 2024 | 33 | 1 | 3.13% | 32 | 1 |
| Dec 31, 2023 | 32 | 6 | 23.08% | 31 | 1 |
| Dec 31, 2022 | 26 | 3 | 13.04% | 25 | 1 |
| Dec 31, 2021 | 23 | 11 | 91.67% | 22 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Gossamer Bio | 162 |
| XBiotech | 87 |
| Clene | 79 |
| Fortress Biotech | 78 |
| Xilio Therapeutics | 76 |
| Oncolytics Biotech | 29 |
| Spero Therapeutics | 25 |
| Cognition Therapeutics | 14 |
CRDF News
- 5 days ago - Cardiff Oncology to Participate in the UBS Global Biopharma Conference - GlobeNewsWire
- 11 days ago - Cardiff Oncology names Leila Alland interim chief medical officer - TheFly
- 11 days ago - Cardiff Oncology Appoints Leila Alland, MD, as Interim Chief Medical Officer - GlobeNewsWire
- 17 days ago - Cardiff Oncology Receives FDA Orphan Drug Designation for Onvansertib in Chronic Myelomonocytic Leukemia - GlobeNewsWire
- 18 days ago - Cardiff Oncology treatment of chronic myelomonocytic leukemia gets orphan status - TheFly
- 7 weeks ago - Cardiff Oncology upgraded to Buy from Neutral at H.C. Wainwright - TheFly
- 7 weeks ago - Cardiff Oncology Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 7 weeks ago - Cardiff Oncology, Nerviano Medical Sciences reach settlement - TheFly